Covid-19 man­u­fac­tur­ing roundup: As­traZeneca strug­gling to make planned vac­cine de­liv­er­ies to EU; J&J out­lines plans to pro­vide 100M dos­es of Covid vac­cine in US as Pfiz­er, Mod­er­na promise speed­i­er de­liv­ery

As J&J neared FDA ap­proval for its Covid-19 vac­cine in the US, with plans to start ship­ping dos­es quick­ly, No­vavax and As­traZeneca are hus­tling along right be­hind in an at­tempt to get in­to the game in North Amer­i­ca. But As­traZeneca con­tin­ues to roil the wa­ters in Eu­rope, where coun­tries have been sore­ly dis­ap­point­ed over short­falls in vac­cine de­liv­ery.

That all got a lit­tle worse this week af­ter Reuters re­port­ed that As­traZeneca told EU of­fi­cials it would de­liv­er less than half of the sup­ply promised for Q2. That re­port was fol­lowed up quick­ly by As­traZeneca, which said it was pulling out the stops to get the full de­liv­ery in place. The EU has been stung by As­traZeneca’s re­port­ed short­fall dur­ing Q1, with less than half of the 90 mil­lion dos­es that were ini­tial­ly planned now ex­pect­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER